当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析

南微医学

(688029)

  

流通市值:134.31亿  总市值:134.31亿
流通股本:1.88亿   总股本:1.88亿

南微医学(688029)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.49亿元,每股收益0.78元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益445255.11万元,未分配利润210064.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产533733.25万元,负债88478.14万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入853,734,897.793,183,783,900.372,380,540,402.291,565,377,051.9
营业总成本670,832,383.742,480,891,3061,755,895,594.021,114,540,760.78
其他经营收益
营业利润181,630,262.24691,689,338.27626,310,214.27450,832,193.49
利润总额182,004,326.77691,153,946.26626,627,247.01449,720,708.02
净利润148,722,793.11582,557,650.02530,090,341.12379,758,886.04
每股收益
其他综合收益-41,562,531.5850,506,340.7129,811,229.0632,508,841.47
综合收益总额107,160,261.53633,063,990.73559,901,570.18412,267,727.51
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,304,918,483.943,642,199,115.163,475,983,589.073,335,431,522.26
非流动资产:
非流动资产合计2,032,413,976.821,821,593,506.61,716,428,619.231,742,031,393.93
资产总计5,337,332,460.765,463,792,621.765,192,412,208.35,077,462,916.19
流动负债:
流动负债合计773,754,431.711,003,875,018.34863,789,230.26797,599,786.74
非流动负债:
非流动负债合计111,026,962.87117,744,833.9384,849,502.0883,062,191.72
负债合计884,781,394.581,121,619,852.27948,638,732.34880,661,978.46
所有者权益(或股东权益):
归属于母公司股东权益合计4,242,095,493.254,130,443,252.664,071,956,863.634,029,665,779.37
股东权益合计4,452,551,066.184,342,172,769.494,243,773,475.964,196,800,937.73
负债和股东权益合计5,337,332,460.765,463,792,621.765,192,412,208.35,077,462,916.19
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计861,399,794.713,422,947,030.982,566,433,223.221,716,779,893.13
经营活动现金流出小计754,997,016.012,735,001,277.352,088,904,722.761,414,597,441.41
经营活动产生的现金流量净额106,402,778.7687,945,753.63477,528,500.46302,182,451.72
投资活动产生的现金流量:
投资活动现金流入小计2,482,436,060.161,626,230,255.44940,416,025.24539,693,248.52
投资活动现金流出小计2,863,735,699.492,551,240,606.251,042,558,227.7549,679,260.3
投资活动产生的现金流量净额-381,299,639.33-925,010,350.81-102,142,202.46-9,986,011.78
筹资活动产生的现金流量:
筹资活动现金流入小计5,027,781.8198,000,002.8198,000,002.872,785,602.8
筹资活动现金流出小计194,851,199.22401,828,217.96387,997,687.53282,338,775.64
筹资活动产生的现金流量净额-189,823,417.42-203,828,215.16-189,997,684.73-209,553,172.84
汇率变动对现金及现金等价物的影响-41,618,903.547,352,730.8930,364,694.2857,358,248.08
现金及现金等价物净增加额-506,339,181.59-433,540,081.45215,753,307.55140,001,515.18
期末现金及现金等价物余额930,336,875.161,436,676,056.752,085,969,445.752,010,217,653.38
补充资料:
现金及现金等价物的净增加额--433,540,081.45-140,001,515.18
最新报告期:2026-05-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投刘慧彬,朱琪璋,王在存,贺菊颖3.203.543.882026-05-28
兴业证券东楠,孙媛媛,黄翰漾3.354.064.872026-05-10
国信证券凌珑,彭思宇,陈曦炳3.554.145.002026-05-05
中泰证券祝嘉琦,谢木青3.324.125.192026-05-02
东吴证券朱国广3.664.345.102026-05-02
TOP↑